139 related articles for article (PubMed ID: 31885715)
1. Prognostic value of glucose transporter 3 expression in hepatocellular carcinoma.
Gao H; Hao Y; Zhou X; Li H; Liu F; Zhu H; Song X; Niu Z; Ni Q; Chen MS; Lu J
Oncol Lett; 2020 Jan; 19(1):691-699. PubMed ID: 31885715
[TBL] [Abstract][Full Text] [Related]
2. Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma.
Xu Y; Zhou X; Zhang S; Nanding A; Xuan Q
Onco Targets Ther; 2022; 15():181-191. PubMed ID: 35250277
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.
Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J
Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of RYBP expression in primary hepatocellular carcinoma].
Jing X; Cai W; Huang B; Chen H; Chen D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 44(4):399-405. PubMed ID: 31113915
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China.
Ke R; Lv L; Li J; Zhang X; Yang F; Zhang K; Jiang Y
Oncol Lett; 2018 Sep; 16(3):3746-3756. PubMed ID: 30127985
[TBL] [Abstract][Full Text] [Related]
7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
8. Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
Chen ZY; Wang T; Gan X; Chen SH; He YT; Wang YQ; Zhang KH
Oncol Lett; 2020 Jun; 19(6):3889-3898. PubMed ID: 32382336
[TBL] [Abstract][Full Text] [Related]
9. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of glucose transporter protein-1 overexpression in human osteosarcoma.
Fan J; Mei J; Zhang MZ; Yuan F; Li SZ; Yu GR; Chen LH; Tang Q; Xian CJ
Oncol Lett; 2017 Aug; 14(2):2439-2445. PubMed ID: 28781680
[TBL] [Abstract][Full Text] [Related]
11. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
[TBL] [Abstract][Full Text] [Related]
12. High glypican-1 expression is a prognostic factor for predicting a poor clinical prognosis in patients with hepatocellular carcinoma.
Chen G; Wu H; Zhang L; Wei S
Oncol Lett; 2020 Nov; 20(5):197. PubMed ID: 32963603
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments.
Zhao LY; Yang DD; Ma XK; Liu MM; Wu DH; Zhang XP; Ruan DY; Lin JX; Wen JY; Chen J; Lin Q; Dong M; Qi JJ; Hu PS; Zeng ZL; Chen ZH; Wu XY
J Cancer; 2019; 10(10):2299-2311. PubMed ID: 31258733
[No Abstract] [Full Text] [Related]
14. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
[TBL] [Abstract][Full Text] [Related]
16. High expression of miR-21 is not a predictor of poor prognosis in all patients with hepatocellular carcinoma.
Yi PS; Li JS
Mol Clin Oncol; 2018 Jun; 8(6):733-739. PubMed ID: 29732156
[TBL] [Abstract][Full Text] [Related]
17. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
18. Glucose transporter-1 expression in squamous cell carcinoma of the tongue.
Choi YS; Kim SJ; Kim DS; Park SJ; Park Y; Shin HJ; Jung KY; Baek SK; Shin BK; Choi JW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Res Treat; 2007 Sep; 39(3):109-15. PubMed ID: 19746220
[TBL] [Abstract][Full Text] [Related]
19. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
Zhao YM; Wang L; Dai Z; Wang DD; Hei ZY; Zhang N; Fu XT; Wang XL; Zhang SC; Qin LX; Tang ZY; Zhou J; Fan J
Int J Cancer; 2011 Nov; 129(10):2463-72. PubMed ID: 21213214
[TBL] [Abstract][Full Text] [Related]
20. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
